These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1806 related items for PubMed ID: 26289307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R, Park TE, Moy S.
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.
    Stone GG, Newell P, Gasink LB, Broadhurst H, Wardman A, Yates K, Chen Z, Song J, Chow JW.
    J Antimicrob Chemother; 2018 Sep 01; 73(9):2519-2523. PubMed ID: 29912399
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
    Mawal Y, Critchley IA, Riccobene TA, Talley AK.
    Expert Rev Clin Pharmacol; 2015 Sep 01; 8(6):691-707. PubMed ID: 26420166
    [Abstract] [Full Text] [Related]

  • 12. Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections.
    Buckman SA, Krekel T, Muller AE, Mazuski JE.
    Expert Opin Pharmacother; 2016 Dec 01; 17(17):2341-2349. PubMed ID: 27758148
    [Abstract] [Full Text] [Related]

  • 13. Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae.
    Santevecchi BA, Smith TT, MacVane SH.
    Int J Antimicrob Agents; 2018 Apr 01; 51(4):629-635. PubMed ID: 29408227
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS, Castanheira M, Flamm RK.
    Antimicrob Agents Chemother; 2017 Apr 01; 61(4):. PubMed ID: 28069649
    [Abstract] [Full Text] [Related]

  • 16. Ceftazidime/Avibactam: A New Antibiotic for Gram-Negative Infections.
    Chahine EB, Sourial M, Ortiz R.
    Consult Pharm; 2015 Dec 01; 30(12):695-705. PubMed ID: 26671269
    [Abstract] [Full Text] [Related]

  • 17. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
    Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK.
    Int J Antimicrob Agents; 2018 Aug 01; 52(2):287-292. PubMed ID: 29654893
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
    Stone GG, Bradford PA, Tawadrous M, Taylor D, Cadatal MJ, Chen Z, Chow JW.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32071051
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 21; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.